The Cooper Companies, Inc. (COO)
| Market Cap | 10.91B -22.9% |
| Revenue (ttm) | 4.24B +4.7% |
| Net Income | 570.30M +39.8% |
| EPS | 2.90 +42.4% |
| Shares Out | 190.16M |
| PE Ratio | 19.76 |
| Forward PE | 12.59 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,885,634 |
| Open | 55.49 |
| Previous Close | 54.88 |
| Day's Range | 55.46 - 57.47 |
| 52-Week Range | 51.01 - 89.83 |
| Beta | 0.83 |
| Analysts | Hold |
| Price Target | 65.80 (+14.63%) |
| Est. Earnings | Dec 3, 2026 |
About COO
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor... [Read more]
Financial Performance
In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for COO stock is "Hold." The 12-month stock price target is $65.8, which is an increase of 14.63% from the latest price.
News
Cooper Companies initiated with an Equal Weight at Barclays
Barclays initiated coverage of Cooper Companies (COO) with an Equal Weight rating and $60 price target The firm rolled out coverage of the medical suppliers and devices group with a…
The Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower -- HBSS
SAN FRANCISCO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- On September 10, 2026, investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company ...
The 15 worst-performing S&P 500 stocks during a dismal September
September has reminded investors that the S&P 500 is heavily weighted at the top. The becnhmark index has risen slightly, but 75% of its component stocks were down for the month.
CooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre Opening
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care
Jana urges Cooper to replace CEO, explore asset sales after performance setbacks
Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence and weighe...
Activist Calls for Cooper Cos. to Seek New CEO.
Cooper Cos. stock rises as activist investor Jana Partners calls for the company to search for a new CEO and sell a key business segment.
Jana Partners urges Cooper Companies to initiate external search for CEO
Jana Partners announced that it has sent a letter to the Board of Directors of The Cooper Companies (COO) highlighting the companies consistent underperformance and calling on it to take…
JANA Partners Sends Letter to Cooper Board of Directors
Calls for Board to Commence Immediate External CEO Search, Appoint New Board Chair and ExploreAsset Sales NEW YORK, Sept. 18, 2026 /PRNewswire/ -- JANA Partners ("JANA") today announced that it has se...
Jana Partners Pushes Cooper to Replace CEO, Explore Contact-Lens Business Sale
Shares of The Cooper Companies ($COO) are in focus after activist investor Jana Partners called for significant changes at the medical-device company, including replacing CEO Albert White and explorin...
Jana Partners pushing Cooper to consider sale of core business, WSJ says
Jana Partners has sent a letter to Cooper Companies (COO) urging the board to replace its CEO and consider the sale of its core businesses, The Wall Street Journal’s Mark…
Jana Partners Pushes Contact-Lens Maker Cooper to Replace Its CEO
The medical-device manufacturer requires an urgent overhaul to address its “chronic underperformance,” the activist hedge fund's letter says.
Cooper Stock Dropped and Put Volume Soared Before Bad News. What Happened?
The medical devices maker took a 5% hit on its stock before two big pieces of news—a guidance cut and the decision not to sell its women's health business.
COO SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cooper Companies
Cooper Companies' quarterly revenue came in roughly $30 million short of Wall Street's consensus and shares fell -- SueWallSt notifies investors of a pending investigation into the Company's SEC repor...
Cooper Companies price target lowered to $75 from $85 at Mizuho
Mizuho lowered the firm’s price target on Cooper Companies (COO) to $75 from $85 and keeps an Outperform rating on the shares. The firm cites near-term “choppiness” for the target…
Barron's Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Cooper Cos. stock has fallen about 25% since Barron's recommended it, but a low valuation, aggressive share buybacks, and takeover potential bolster the bull case.
Cooper Cos. Stock Drops After Soft Outlook, News It Won't Seek Deal
Shares of Cooper Cos. are pacing the S&P 500's decliners Thursday after the maker of medical devices reported mixed results, issued soft guidance and wrapped up a strategic review without plans to see...
Thursday's First Moves: AEO, M & COO Sell Off After Earnings
American Eagle Outfitters (AEO) posted a "mixed bag" earnings report, according to George Tsilis, who explains why the clothing retailer company is seeing pressure from pinched U.S. consumers. Macy's ...
Cooper Companies falls -15.0%
Cooper Companies (COO) is down -15.0%, or -$9.52 to $53.96.
Cooper Companies downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Cooper Companies (COO) to Market Perform from Outperform following “two surprises” in last night’s fiscal Q3 earnings report – namely, a CooperVision miss due to inventory des...
Cooper Companies price target lowered to $66 from $75 at UBS
UBS lowered the firm’s price target on Cooper Companies (COO) to $66 from $75 and keeps a Neutral rating on the shares.
Cooper Companies price target lowered to $73 from $86 at Needham
Needham analyst David Saxon lowered the firm’s price target on Cooper Companies (COO) to $73 from $86 and keeps a Buy rating on the shares. The Q3 revenue missed and…
Cooper Companies price target lowered to $58 from $71 at JPMorgan
JPMorgan lowered the firm’s price target on Cooper Companies (COO) to $58 from $71 and keeps a Neutral rating on the shares. The company reported a fiscal Q3 miss and…
Cooper Companies price target lowered to $60 from $80 at Citi
Citi analyst Joanne Wuensch lowered the firm’s price target on Cooper Companies (COO) to $60 from $80 and keeps a Neutral rating on the shares. The company’s decision to maintain…
Cooper Companies price target lowered to $70 from $85 at Stifel
Stifel lowered the firm’s price target on Cooper Companies (COO) to $70 from $85 and keeps a Buy rating on the shares after the company decided to keep the CooperSurgical…
Cooper Companies price target lowered to $61 from $66 at Wells Fargo
Wells Fargo lowered the firm’s price target on Cooper Companies (COO) to $61 from $66 and keeps an Equal Weight rating on the shares. The firm says no CSI sale…